ObsEva Competitors and Similar CompaniesClear all

ObsEva's competitors and similar companies include NIOX and Affimed N.V..
ObsEva
ObsEva
ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine.
NIOX
NIOX
NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
Affimed N.V.
Affimed N.V.
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
Founding Date
Founding Date
2012
Founding Date
2006
Founding Date
2000
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Plan-les-Ouates, CH HQ
Boston, US
Sacramento, US
Locations
Morrisville, US HQ
Bad Homburg Vor Der Höhe, DE
Uppsala, SE
Morrisville, US
Locations
Heidelberg, DE HQ
Employees
Employees
811% decrease
Employees
91
Employees
76
Valuation ($)
Valuation ($)
N/A
Valuation ($)
340.9 m
Valuation ($)
52.5 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
£48.7m (FY, 2025)
Revenue (est.)
€8.3m (FY, 2023)
Cost of goods
Cost of goods
N/A
Cost of goods
£11.1m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
£38.2m (FY, 2025)
Gross profit
€13m (FY, 2023)
Net income
Net income
N/A
Net income
£7m (FY, 2025)
Net income
(€105.9m) (FY, 2023)

Funding

Total funding raised
Total funding raised
$ 92.9m
Total funding raised
$ 122.8m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

NIOX
HQ
Morrisville, US
Employees
91

NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies

View company
Affimed N.V.
HQ
Heidelberg, DE
Employees
76

Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.

View company